Dominique Baeten Selected Research

Dominique Baeten Research Topics

Disease

33	Rheumatoid Arthritis 01/2019 - 03/2002
27	Inflammation (Inflammations) 01/2020 - 03/2002
22	Ankylosing Spondylitis 01/2020 - 12/2002
15	Arthritis (Polyarthritis) 05/2015 - 01/2004
13	Synovitis 01/2012 - 02/2004
12	Spondylarthropathies 01/2016 - 03/2002
11	Necrosis 01/2018 - 03/2002
9	Spondylarthritis (Spinal Arthritis) 12/2014 - 06/2006
8	Psoriatic Arthritis 01/2019 - 01/2005
7	Experimental Arthritis 06/2021 - 10/2008
7	Axial Spondyloarthritis 01/2020 - 09/2014
5	Crohn Disease (Crohn's Disease) 01/2016 - 09/2002
5	Osteoarthritis 11/2011 - 07/2005
4	Autoimmune Diseases (Autoimmune Disease) 06/2021 - 01/2010
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 01/2017
4	Hyperplasia 01/2016 - 01/2005
3	Infections 01/2019 - 07/2005
2	Rheumatic Diseases (Rheumatism) 01/2014 - 01/2013
1	Hidradenitis Suppurativa 11/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2021
1	Fibrosis (Cirrhosis) 06/2021
1	type 2C Congenital disorder of glycosylation 01/2019
1	Multiple Sclerosis 01/2019
1	Skin Diseases (Skin Disease) 01/2018
1	Non-Radiographic Axial Spondyloarthritis 01/2018
1	Back Pain (Backache) 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Neutropenia 12/2015
1	Body Weight (Weight, Body) 12/2015
1	Candidiasis (Moniliasis) 12/2015
1	Gout 05/2014
1	Melanoma (Melanoma, Malignant) 03/2014
1	Abscess 11/2013
1	Disease Progression 04/2013
1	Asthma (Bronchial Asthma) 01/2013
1	Hepatitis B 01/2013

Drug/Important Bio-Agent (IBA)

19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2002
15	CytokinesIBA 01/2020 - 10/2002
15	Interleukin-17 (Interleukin 17)IBA 01/2020 - 04/2009
11	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2005
11	Infliximab (Remicade)FDA Link 08/2014 - 03/2002
10	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2004
9	Monoclonal AntibodiesIBA 01/2018 - 03/2002
7	Biological ProductsIBA 01/2020 - 08/2003
7	LigandsIBA 01/2019 - 12/2002
7	secukinumabIBA 06/2017 - 11/2013
7	Etanercept (Enbrel)FDA Link 08/2014 - 01/2004
6	AutoantibodiesIBA 12/2014 - 04/2005
5	bimekizumabIBA 11/2021 - 01/2018
5	Interleukin-23 (Interleukin 23)IBA 01/2020 - 12/2011
5	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 08/2005
4	C-Reactive ProteinIBA 01/2018 - 10/2016
4	ImmunosorbentsIBA 05/2014 - 09/2004
4	EnzymesIBA 05/2014 - 09/2004
4	AntibodiesIBA 08/2013 - 03/2008
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017 - 09/2014
3	CollagenIBA 03/2014 - 04/2013
3	AutoantigensIBA 03/2014 - 06/2003
3	acetyl 4-aminosalicylic acidIBA 04/2013 - 08/2005
3	Messenger RNA (mRNA)IBA 11/2011 - 11/2008
3	ChemokinesIBA 07/2008 - 10/2002
2	InterleukinsIBA 01/2020 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 07/2005
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2015 - 06/2006
2	Toll-Like Receptor 4IBA 05/2014 - 07/2005
2	Immunomodulating AgentsIBA 01/2013 - 12/2010
2	Immunoglobulin M (IgM)IBA 08/2011 - 07/2005
2	OsteoprotegerinIBA 04/2011 - 03/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2008 - 08/2006
2	Matrix Metalloproteinases (MMPs)IBA 06/2006 - 09/2004
2	EpitopesIBA 08/2005 - 02/2004
2	Interleukin-10 (Interleukin 10)IBA 02/2004 - 03/2002
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2021
1	seletalisibIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Certolizumab Pegol FDA Link 01/2019
1	golimumab FDA Link 01/2019
1	risankizumabIBA 01/2018
1	Tumor Necrosis Factor InhibitorsIBA 01/2017
1	nilotinib FDA Link 10/2016
1	Interleukin-9 (Interleukin 9)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	Ustekinumab (CNTO 1275)FDA Link 07/2014
1	Interleukin-12 (IL 12)IBA 07/2014
1	brodalumabIBA 07/2014
1	ixekizumabIBA 07/2014
1	Uric Acid (Urate)IBA 05/2014
1	Rituximab (Mabthera)FDA Link 01/2014
1	B-Cell Maturation AntigenIBA 08/2013
1	Cyclophilins (Cyclophilin)IBA 08/2013
1	B-Cell Activating FactorIBA 08/2013
1	Fibrinogen (Factor I)FDA Link 04/2013
1	VaccinesIBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 08/2012

Therapy/Procedure

18	Therapeutics 01/2020 - 03/2002
1	Ligation 01/2017
1	Biological Therapy 01/2014